
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Nuvalent Inc is a biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets. Nuvalent Inc is a biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -11.5 | -16.2383507484 | 70.82 | 72.61 | 59.32 | 694426 | 67.14163986 | CS |
4 | -7.9 | -11.7524546266 | 67.22 | 79.03 | 59.32 | 612218 | 72.45664461 | CS |
12 | -12.78 | -17.7253814147 | 72.1 | 91.5 | 59.32 | 521395 | 75.98886461 | CS |
26 | -44.05 | -42.6139111928 | 103.37 | 106.32 | 59.32 | 480922 | 82.47148245 | CS |
52 | -10.89 | -15.5106110241 | 70.21 | 113.51 | 59.32 | 469841 | 81.98156688 | CS |
156 | 46.72 | 370.793650794 | 12.6 | 113.51 | 7.09 | 384357 | 61.50762051 | CS |
260 | 41.22 | 227.73480663 | 18.1 | 113.51 | 7.09 | 344493 | 57.67067524 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions